The patients with G2 (moderately differentiated) tumours had a significantly higher gene expression level of E2F2 than patients with low-grade G1 (well-differentiated) tumours (p-Value = 0.031) in tumour samples. This evidence concerns the gene E2F2 and neoplasm.